• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新疗法改变游戏规则:初级保健中的丙型肝炎治疗。

New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care.

机构信息

Facente Consulting, 5601 Van Fleet Avenue, Richmond, CA 94804, USA.

Community Health Equity and Promotion Branch, San Francisco Department of Public Health, 25 Van Ness Suite 500, San Francisco, CA 94102, USA.

出版信息

Infect Dis Clin North Am. 2018 Jun;32(2):313-322. doi: 10.1016/j.idc.2018.02.012.

DOI:10.1016/j.idc.2018.02.012
PMID:29778258
Abstract

In the pre-direct-acting antiviral era, hepatitis C virus (HCV) treatments were complex and largely managed by hepatologists, gastroenterologists, and infectious disease physicians. As direct-acting antivirals have driven up demand for treatment, the relative scarcity of these specialists has created a bottleneck effect, resulting in only a fraction of HCV-infected individuals offered treatment. The San Francisco Health Network is a safety net system of care. Its intervention was designed to be sustainable and scalable; with minimal time commitments for training providers, primary care-based HCV treatment increased 3-fold in a period of just over 3 years.

摘要

在直接作用抗病毒药物时代之前,丙型肝炎病毒 (HCV) 的治疗方法复杂,主要由肝病专家、胃肠病专家和传染病专家管理。随着直接作用抗病毒药物的需求增加,这些专家相对稀缺,造成了治疗瓶颈,导致只有一小部分 HCV 感染者得到了治疗。旧金山健康网络是一个医疗保障系统。其干预措施旨在具有可持续性和可扩展性;通过对提供者进行最小时间的培训承诺,在短短 3 年多的时间里,以初级保健为基础的 HCV 治疗增加了 3 倍。

相似文献

1
New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care.新疗法改变游戏规则:初级保健中的丙型肝炎治疗。
Infect Dis Clin North Am. 2018 Jun;32(2):313-322. doi: 10.1016/j.idc.2018.02.012.
2
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?直接作用抗病毒药物治疗 HIV 感染者的丙型肝炎病毒感染 - “迈向根治”?
J Infect. 2017 Sep;75(3):234-241. doi: 10.1016/j.jinf.2017.05.008. Epub 2017 Jun 2.
3
Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.将丙型肝炎感染的管理纳入初级保健:丙型肝炎消除工作的关键。
J Gen Intern Med. 2022 Oct;37(13):3435-3443. doi: 10.1007/s11606-022-07628-9. Epub 2022 Apr 28.
4
Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.
Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12796. Epub 2017 Nov 28.
5
Hepatitis C virus virology and new treatment targets.丙型肝炎病毒病毒学与新的治疗靶点
Expert Rev Anti Infect Ther. 2009 Apr;7(3):329-50. doi: 10.1586/eri.09.12.
6
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.卢旺达直接作用抗病毒药物治疗丙型肝炎的患者和医疗服务提供者体验:对障碍和促进因素的定性探索。
BMC Public Health. 2020 Jun 16;20(1):946. doi: 10.1186/s12889-020-09000-0.
7
A pilot study to expand treatment of chronic hepatitis C in resource-limited settings.在资源有限的环境下扩大慢性丙型肝炎治疗的初步研究。
Antiviral Res. 2017 Oct;146:184-190. doi: 10.1016/j.antiviral.2017.09.007. Epub 2017 Sep 18.
8
[Therapeutic update in hepatitis C].[丙型肝炎的治疗进展]
Rev Esp Quimioter. 2015 Sep;28 Suppl 1:48-51.
9
Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.丙型肝炎病毒1型感染的治疗进展:来自传染病药剂师协会的见解
Pharmacotherapy. 2016 Feb;36(2):203-17. doi: 10.1002/phar.1700. Epub 2016 Feb 5.
10
[Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].直接作用抗病毒药物治疗慢性丙型肝炎病毒感染患者的有效性和安全性
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):175-178. doi: 10.3760/cma.j.issn.1007-3418.2018.03.004.

引用本文的文献

1
Hepatitis C-Everything a Primary Care Physician Needs to Know About Diagnosis, Management, and Follow-Up.丙型肝炎——基层医疗医生需要了解的关于诊断、管理及随访的一切。
J Clin Med. 2025 Jul 7;14(13):4801. doi: 10.3390/jcm14134801.
2
Prescribing direct-acting antivirals for hepatitis C treatment: a scoping review of factors that influence primary care providers.开具用于丙型肝炎治疗的直接抗病毒药物:对影响初级保健提供者的因素的范围综述
BMC Prim Care. 2025 May 13;26(1):157. doi: 10.1186/s12875-025-02865-3.
3
Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C Infection among People Who Inject Drugs.
由工作人员协助的远程医疗服务提供,用于治疗注射吸毒者中的丙型肝炎感染。
Healthcare (Basel). 2024 Mar 25;12(7):715. doi: 10.3390/healthcare12070715.
4
Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations: A Nonrandomized Controlled Trial.针对边缘化人群的社区诊断点丙型肝炎治疗:一项非随机对照试验。
JAMA Netw Open. 2023 Oct 2;6(10):e2338792. doi: 10.1001/jamanetworkopen.2023.38792.
5
Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021.中国丙型肝炎直接抗病毒治疗的应用:一项 2017 年至 2021 年的回顾性研究。
Infect Dis Poverty. 2023 Mar 28;12(1):28. doi: 10.1186/s40249-023-01081-4.
6
Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.伊朗注射毒品人群中的丙型肝炎病毒流行率、决定因素和关怀传递。
Drug Alcohol Depend. 2023 Feb 1;243:109751. doi: 10.1016/j.drugalcdep.2022.109751. Epub 2023 Jan 2.
7
Predictors of linkage to hepatitis C virus care among people living with HIV with hepatitis C infection and the impact of loss to HIV follow-up.丙型肝炎病毒感染的艾滋病毒感染者接受丙型肝炎治疗的关联预测因素及艾滋病毒随访失访的影响
Health Sci Rep. 2022 May 23;5(3):e645. doi: 10.1002/hsr2.645. eCollection 2022 May.
8
Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.将丙型肝炎感染的管理纳入初级保健:丙型肝炎消除工作的关键。
J Gen Intern Med. 2022 Oct;37(13):3435-3443. doi: 10.1007/s11606-022-07628-9. Epub 2022 Apr 28.
9
Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action.在全球大流行期间消除丙型肝炎:行动中韧性的案例研究。
Public Health Rep. 2022 Jul-Aug;137(4):649-654. doi: 10.1177/00333549221083741. Epub 2022 Apr 9.
10
Implementation of a Hepatitis C Treatment Program Into a Primary Care Residency Clinic.将丙型肝炎治疗项目纳入基层医疗住院医师诊所
PRiMER. 2021 Jan 22;5:1. doi: 10.22454/PRiMER.2021.532368. eCollection 2021.